Premium
Detection of opiate‐enhanced increases in DNA damage, HPRT mutants, and the mutation frequency in human HUT‐78 cells
Author(s) -
Shafer David A.,
Xie Yiping,
Falek Arthur
Publication year - 1994
Publication title -
environmental and molecular mutagenesis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1
H-Index - 87
eISSN - 1098-2280
pISSN - 0893-6692
DOI - 10.1002/em.2850230107
Subject(s) - comet assay , mutation frequency , mutagen , ethyl methanesulfonate , mutant , sister chromatid exchange , mutagenesis , microbiology and biotechnology , hypoxanthine guanine phosphoribosyltransferase , dna damage , opiate , clastogen , biology , mutation , genotoxicity , sister chromatids , morphine , genetics , dna repair , dna , chemistry , pharmacology , chromosome , toxicity , gene , organic chemistry , receptor
In previous studies we have shown highly significant increases in chromosome damage and sister chromatid exchanges in heroin addicts, particularly when caffeine and metabolic inhibitors are added to the medium. Using human HUT‐78 T‐cell cultures, we now find direct in vitro evidence of opiate‐induced or opiate‐promoted mutagenesis via several assay systems. First, with microgel electrophoresis (MGE), we observed graded, dose‐dependent, significant increases ( P < .0001) in the frequency of comet tails of fragmented DNA when cells were treated with morphine alone (5 × 10 −9 M up to 10 −7 M) or when co‐treated with the more potent mutagen, ethylmethanesulfonate (EMS). There were also dose‐dependent increases in the lengths and densities of the comet tails observed. These findings were confirmed by a series of MGE experiments in which several days of morphine exposure preceded a 2‐hr pulse of EMS. Second, mutant frequency (MF) assays also indicated significant opiate effects. These studies required separate assessment of cloning efficiencies and the frequencies of TG‐resistant, HPRT‐deficient mutant clones under four test conditions: no treatment, morphine alone for 4 days, morphine plus EMS, and EMS alone. Prior to the treatment phase, aminopterin was used to eliminate background HPRT mutations. The medium was changed after the treatment phase, the cells were allowed to express mutant pheno‐types, and then TG was added and resistant mutant clones counted after 16 days. The background MF level for controls and for cells treated with EMS alone were negligible at 5.12 × 10 −8 and 7.25 × 10 −8 , respectively. In the cells treated with morphine alone or morphine plus EMS, MF levels increased very significantly ( P < .001) by >100‐fold to 5.1 × 10 −6 and 7.0 × 10 −6 , respectively. Cloning efficiency also decreased significantly with both morphine‐exposed conditions. Preliminary analysis with the single strand conformational polymorphism (SSCP) procedure following 6‐thioguanine (TG) selection, also confirmed the occurrence of Exon 3 mutants of the HPRT gene in cells exposed to morphine plus EMS. It appears that brief EMS exposure can be repaired, whereas, if morphine exposure persists through one or more cell cycles, direct or indirect mutagenesis is initiated. © 1994 Wiley‐Liss, Inc.